Cargando…
Benzo[f]indole-4,9-dione Derivatives Effectively Inhibit the Growth of Triple-Negative Breast Cancer
Triple-negative breast cancer (TNBC) is a subtype of breast cancer with poor clinical outcome, and currently no effective targeted therapies are available. Indole compounds have been shown to have potential antitumor activity against various cancer cells. In the present study, we found that new four...
Autores principales: | Guerra, Fabiana Sélos, Dias, Flaviana Rodrigues Fintelman, Cunha, Anna Claudia, Fernandes, Patricia Dias |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8347180/ https://www.ncbi.nlm.nih.gov/pubmed/34361566 http://dx.doi.org/10.3390/molecules26154414 |
Ejemplares similares
-
Discovery of Benzo[f]indole-4,9-dione Derivatives as New Types of Anti-Inflammatory Agents
por: Chen, You-Ren, et al.
Publicado: (2015) -
Novel Single Inhibitor of HDAC6/8 and Dual Inhibitor of PI3K/HDAC6 as Potential Alternative Treatments for Prostate Cancer
por: Guerra, Fabiana Sélos, et al.
Publicado: (2021) -
12-(4-Methoxybenzoyl)-2-methylbenzo[f]pyrido[1,2-a]indole-6,11-dione
por: Novina, J. Josephine, et al.
Publicado: (2012) -
New 1H-Benzo[f]indazole-4,9-diones Conjugated with C-Protected Amino Acids and Other Derivatives: Synthesis and in Vitro Antiproliferative Evaluation
por: Molinari, Aurora, et al.
Publicado: (2015) -
Synthesis of Novel Dihydropyridothienopyrimidin-4,9-dione Derivatives
por: Kim, Youngjae, et al.
Publicado: (2015)